CDMRP Mesothelioma Awards

A total of $7.7 million has been awarded to mesothelioma research through the Peer Reviewed Medical Research Program and the Peer Reviewed Cancer Research Program, both divisions of the Congressionally Directed Medical Research Program, which is administered by the Department of Defense since Fiscal Year 2008. 



Courtney Broaddus, M.D.

$1.4 million

PRMRP Investigator-Initiated Research Award

Role of Macrophage-Induced Inflammation in Mesothelioma



HarveyPass, M.D.

Margaret E. Huflejt, Ph.D.


PRMRP Investigator-Initiated Research Award: Partnering PI Option

Glyco-Immune Diagnostic Signatures and Therapeutic Targets of Mesothelioma


Lee Krug, M.D.

$1.5 Million

PRMRP Clinical Trial Award

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy


Joseph TestaPh.D., FACMG


PRCRP Idea Award

Role of Inflammasome in Asbestos-Induced Mesothelioma Formation



Brian Marples, Ph.D.


PRMRP Concept Award

Improving Outcome in Malignant Pleural Mesothelioma (MPM) Using Pulsed-Protracted External Beam Radiation (PERT) and Intrapleural Delivery of Stem Cells


Youngbaek Kim DVM, M.S., Ph.D., Dipl. ACVP


PRMRP Concept Award

The Fate of Intrapleurally Injected Bone Marrow-Derived Stem Cells in Mice with Pleural Mesothelioma


Jaime F. Mata, Ph.D.


PRMRP Concept Award

Noninvasive Cytoreductive Surgical Treatment of Lung Mesothelioma


Michel Sadelain, M.D., Ph.D., and Prasad Adusumilli, M.D.

$2.6 million

Technology/Therapeutic Development Award

Regional Immune Interventions to Enhance Mesothelin Targeted Immunotherapy of Malignant Pleural Mesothelioma


FY2011(Recommended for Funding)


Bruce Robinson


Discovery Award

Targeting Immunological “Restrainers”: Understanding the Immunology Behind Combonation Chemoimmunotherapy to Improve the Treatment of Malignant Mesothelioma


Sherven Sharma


Discovery Award

Mesothelioma Snail Mediated Modulation of Inflammatory Response


Ravi Salgia


Discovery Award

P13K as a Therapeutic Target in Malignant Pleural Mesothelioma



Lynn Heasley


Discovery Award

Targeting Fibroblast Growth Factor Receptor Signaling Pathways in Mesothelioma

Believe in a Cure!

Contact us here for immediate expert help and a free copy of the book "100 Questions & Answers About Mesothelioma."

(877) END-MESO
(877) 363-6376